Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > CONFLICT OF INTEREST
View:
Post by PBaelishh on Jun 05, 2023 10:18am

CONFLICT OF INTEREST

CONFLICT OF INTEREST
 
There are regulations regarding directors and CEOs disclosing their ownership stake in other entities, not to mention owning another entity, as it appears in this case, outright.  The rationale for such a disclosure requirement is to ensure that there is no CONFLICT OF INTEREST, anywhere, no matter how small.
 
Perception is everything.
 
Given there is no mention of Gagnon's ownership of Prodev Pharma in any Ceapro publcly available documents that I have been able to find...
(1) Is Gilles Gagnon using "Consulting" fees paid by Ceapro to the benefit of PRODEV PHARMA?
(2) Is Gilles Gagnon devoting time to PRODEV PHARMA that he is representing he is devoting to Ceapro?
 
It may very well be that it is nothing... then why not disclose it?  The lack of disclosure of Gagnon's ownership of Prodev Pharma smells.  
 
The board is either ignorant to it (too trusting and has not asked the question) and failed from a competence perspective or aware of it and complicit.
 
Lastly, while Gagnon can spin the numbers with his nonsense, this is an issue for the regulators now - the OSC and TMX.
 
Comment by prophetoffactz on Jun 05, 2023 11:03am
PBaelishh, "Given there is no mention of Gagnon's ownership of Prodev Pharma in any Ceapro publcly available documents that I have been able to find..." Information Circular for the AGM. pg. 13 "Prodev Pharma Inc., a company wholly owned by Mr. Gagnon, was paid consulting fees for his services as Chief Executive Officer" pg. 22 "President, Prodev Pharma Inc. since ...more  
Comment by PBaelishh on Jun 05, 2023 11:07am
My mistake, thank you for posting. Questions remain then: (1) How many hours per week does Gilles Gagnon devote to Prodev Pharma? (2) How many hours per week does Gilles Gagnon devote to Ceapro?
Comment by prophetoffactz on Jun 05, 2023 11:55am
"Questions remain then: (1) How many hours per week does Gilles Gagnon devote to Prodev Pharma? (2) How many hours per week does Gilles Gagnon devote to Ceapro?" "Management services for the Corporation are not, to any material degree, performed by persons other than the directors or executive officers of the Corporation" pg. 20 Information Circular "The CEO or ...more  
Comment by PBaelishh on Jun 05, 2023 4:13pm
Sorry, obfuscation is not the answer. A QUANTITATIVE response consisting of 5 characters (2 numbers - carriage return - 2 numbers) is what I (we) are looking for, assuming the response is to be made respectively. ...or perhaps you had a copy-paste-copy-copy-paste-copy-paste-copy-paste-copy-paste-copy-paste-copy-paste-copy-paste-copy-paste-copy-paste-copy-paste-copy-paste-paste-copy-paste-copy ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities